PMGC Holdings Inc. (ELAB)Healthcare | Biotechnology | Newport Beach, United States | NasdaqCM
1.09 USD
-0.03
(-2.679%) ⇩
(July 13, 2026, 4 p.m.
EDT)
After hours: 1.06 -0.03 (-0.030%) ⇩ (July 13, 2026, 7:58 p.m. EDT) |
Hot Take ↕ | July 11, 2026, 6:30 a.m. EDT
The immediate outlook is severely clouded by a catastrophic price collapse, with the stock trading at roughly 99.7% below its level just one year ago. While recent headlines celebrate strategic pivots toward aerospace and biotech, the market has already priced in a complete loss of value, leaving the current price of $1.12 disconnected from the company's historical valuation. Fundamentally, the business is in distress, reporting massive negative gross and operating margins alongside significant free cash flow outflows, which suggests the current operations are burning capital rather than generating value. Although the balance sheet shows a positive current ratio and the company has secured some new financing, the inability to generate profit or positive cash flow from existing assets creates a precarious environment for any near-term recovery. With no dividend history to provide income and a statistical forecast indicating continued downward pressure despite very low model confidence, the security presents a high-risk scenario where the gap between the optimistic news cycle and the brutal financial reality remains dangerously wide. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.080865 |
| AutoETS | 0.419230 |
| AutoARIMA | 0.419230 |
| MSTL | 0.446965 |
Forecast horizon: 45 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 29% |
| H-stat | 1.26 |
| Ljung-Box p | 0.001 |
| Jarque-Bera p | 0.689 |
| Excess Kurtosis | -0.63 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 63.119 |
| Revenue per Share | 9.796 |
| Market Cap | 4,952,688 |
| Beta | -0.24 |
| Previous Name | Elevai Labs, Inc. |
| Website | https://pmgcholdings.com |
| Attribute | Value |
|---|---|
| 52 Week Change | -0.9948249 |
| Address1 | 120 Newport Center Drive |
| Address2 | Suite 249 |
| All Time High | 500,345.25 |
| All Time Low | 1.02 |
| Ask | 1.33 |
| Ask Size | 2 |
| Average Daily Volume10 Day | 10,018,860 |
| Average Daily Volume3 Month | 3,153,357 |
| Average Volume | 3,153,357 |
| Average Volume10Days | 10,018,860 |
| Beta | -0.239 |
| Bid | 0.8136 |
| Bid Size | 2 |
| Book Value | 6.509 |
| City | Newport Beach |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 1.09 |
| Current Ratio | 1.45 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 1.15 |
| Day Low | 1.0301 |
| Debt To Equity | 63.119 |
| Display Name | PMGC |
| Ebitda | -9,028,514 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | 0.255 |
| Enterprise To Revenue | -1.808 |
| Enterprise Value | -2,300,154 |
| Eps Trailing Twelve Months | -150.06 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 1.6538 |
| Fifty Day Average Change | -0.5638 |
| Fifty Day Average Change Percent | -0.34091184 |
| Fifty Two Week Change Percent | -99.48249 |
| Fifty Two Week High | 309.89474 |
| Fifty Two Week High Change | -308.80475 |
| Fifty Two Week High Change Percent | -0.9964827 |
| Fifty Two Week Low | 1.02 |
| Fifty Two Week Low Change | 0.07000005 |
| Fifty Two Week Low Change Percent | 0.06862751 |
| Fifty Two Week Range | 1.02 - 309.89474 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,700,577,000,000 |
| Float Shares | 4,089,830 |
| Free Cashflow | -2,403,837 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 32 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | -0.63146996 |
| Gross Profits | -803,280 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.09991 |
| Held Percent Institutions | 0.01572 |
| Implied Shares Outstanding | 4,543,751 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Ipo Expected Date | 2,023-11-21 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,773,100,800 |
| Last Split Factor | 1:6 |
| Long Business Summary | PMGC Holdings Inc., a biopharmaceutical company, focuses on the development and acquisition of aesthetic medicines and therapeutic products. It operates through three segments: corporate, treasury and biosciences; IT packaging solutions; and precision engineering and machining. The company's lead product includes EL-22, a first-in-class engineered probiotic approach to address obesity's pressing issue of preserving muscle while on weight loss treatments, including GLP-1 receptor agonists. It is also involved in the medical scientific research and development activities, as well as operating investment firms; providing packaging solutions to industrial and consumer markets; and design and production of high-tolerance components for industrial and technological applications. The company was formerly known as Elevai Labs, Inc. and changed its name to PMGC Holdings Inc. in December 2024. PMGC Holdings Inc. was incorporated in 2020 and is based in Newport Beach, California. |
| Long Name | PMGC Holdings Inc. |
| Market | us_market |
| Market Cap | 4,952,688 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_1683617420 |
| Most Recent Quarter | 1,774,915,200 |
| Name Change Date | 2,026-07-09 |
| Net Income To Common | -11,186,689 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 5,059,012 |
| Open | 1.06 |
| Operating Cashflow | -7,566,060 |
| Operating Margins | -4.8468 |
| Payout Ratio | 0.0 |
| Phone | 866 445 4886 |
| Post Market Change | -0.03000009 |
| Post Market Change Percent | -2.7523017 |
| Post Market Price | 1.06 |
| Post Market Time | 1,783,987,082 |
| Prev Name | Elevai Labs, Inc. |
| Previous Close | 1.12 |
| Price Hint | 4 |
| Price To Book | 0.16746044 |
| Price To Sales Trailing12 Months | 3.893384 |
| Profit Margins | 0.0 |
| Quick Ratio | 1.394 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | none |
| Region | US |
| Regular Market Change | -0.03 |
| Regular Market Change Percent | -2.67857 |
| Regular Market Day High | 1.15 |
| Regular Market Day Low | 1.0301 |
| Regular Market Day Range | 1.0301 - 1.15 |
| Regular Market Open | 1.06 |
| Regular Market Previous Close | 1.12 |
| Regular Market Price | 1.09 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 3,883,029 |
| Return On Assets | -0.33279 |
| Return On Equity | -1.07902 |
| Revenue Per Share | 9.796 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 4,543,751 |
| Shares Percent Shares Out | 0.0729 |
| Shares Short | 331,075 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 600,477 |
| Short Name | PMGC Holdings Inc. |
| Short Percent Of Float | 0.0729 |
| Short Ratio | 0.16 |
| Source Interval | 15 |
| State | CA |
| Symbol | ELAB |
| Total Cash | 15,210,586 |
| Total Cash Per Share | 3.348 |
| Total Debt | 7,957,106 |
| Total Revenue | 1,272,078 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -150.06 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 46.538143 |
| Two Hundred Day Average Change | -45.448143 |
| Two Hundred Day Average Change Percent | -0.97657835 |
| Type Disp | Equity |
| Volume | 3,883,029 |
| Website | https://pmgcholdings.com |
| Zip | 92,660 |